Bain Capital, LP is one of the world’s leading private investment firms with approximately $185 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Allyson S. Rinderle

Allyson S. Rinderle

Managing Director
Life Sciences
Boston

Experience

Allyson Rinderle joined Bain Capital in 2022. She is a Managing Director on the Life Sciences team.

Prior to joining Bain Capital, Allyson was a Principal at KKR focused on the life sciences on Healthcare Growth Equity and Private Equity teams. Before KKR, Allyson was a Vice President at Longitude Capital, a healthcare venture growth firm where she focused on biopharmaceutical investments. Previously, she held analyst roles at the life sciences investment firm Aisling Capital and in J.P. Morgan’s Health Care Investment Banking practice.


Education

Allyson received an MBA from Stanford Graduate School of Business, where she was an Arjay Miller Scholar. She received a BS in biomedical engineering with distinction from Yale University, graduating magna cum laude, Tau Beta Pi, and Phi Beta Kappa.